drugset / Trial / NCT03383042

Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of JP-1366 Oral Administration in Healthy Male Subjects

NCT03383042

Phase 1 Completed 115 enrolled Jeil Pharmaceutical Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

Clinical trial to investigate the safety, tolerability and pharmacokinetics and pharmacodynamics of JP-1366 oral administration in healthy male subjects

Timeline

Start
2017-12-22
Primary completion
2018-11-23
Completion
2019-04-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 40 mg
Subject JP-1366 Unknown Oral